From: Factors associated with symptomatic pseudotumors following metal-on-metal total hip arthroplasty
Symptomatic | Asymptomatic | P | |
---|---|---|---|
Sex | |||
Female | 15 | 34 | 0.154 |
Male | 1 | 12 | |
Age (years)a | 63.1 | 64.1 | 0.803 |
BMI (kg/m2)a | 25.4 | 23.4 | 0.036 |
Head diameter (mm)a | 42.6 | 41.7 | 0.454 |
Cup inclination (°)a | 45.2 | 43.5 | 0.790 |
Cup anteversion (°)a | 14.1 | 13.3 | 0.494 |
Time of MRI screening (months)a | 45.7 | 49.7 | 0.359 |
Pseudotumor size (mm2)a | 1812 | 642 | 0.003 |
Position of pseudotumor | |||
Anterior | 10 | 13 | 0.019 |
Posterolateral | 6 | 33 | |
Pseudotumor type | |||
Cystic | 4 | 31 | 0.007 |
Mixed cystic solid and solid | 12 | 15 | |
Change of pseudotumor size | |||
Decreased | 2 | 6 | 0.083 |
Increased | 4 | 8 | |
No change | 0 | 13 | |
Cobalt level (μg/L)a | 11.7 | 8.8 | 0.176 |
Chromium level (μg/L)a | 10.3 | 6.2 | 0.171 |